Amanote Research
Register
Sign In
Table S1: Expected and Observed Mortality of Ae. Aegypti Larvae Post-Combined Treatment With M. Robertsii and Avermectins
doi 10.7717/peerj.7931/supp-2
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 1: Mortality Dynamics of Ae. Aegypti Larvae After Treatment With M. Robertsii (1 × 106 Conidia/Ml), Avermectins (0.00001%) and Their Combination.
Figure 6: Acid Protease Activity in Whole-Body Homogenates of Ae. Aegypti Larvae After Treatment With M. Robertsii, Avermectins and Their Combination.
Figure 4: Dopamine Concentration in Whole-Body Homogenates of Ae. Aegypti Larvae After Treatment With M. Robertsii, Avermectins and Their Combination.
Figure 8: Colony Forming Units of M. Robertsii (A) and Cultivable Bacteria (B) in Whole-Body Homogenates of Ae. Aegypti Larvae After Treatment With M. Robertsii, Avermectins and Their Combination.
Figure 3: Activity of PO in the Whole-Body Homogenates of Ae. Aegypti Larvae After Treatment With M. Robertsii, Avermectins and Their Combination.
Figure 5: GST (A) and EST (B) Activity in Whole-Body Homogenates of Ae. Aegypti Larvae After Treatment With M. Robertsii, Avermectins and Their Combination.
Figure 2: The Colonization of Ae. Aegypti by M. Robertsii.
Data S1: Raw Data Using for Analysis of Ae. Aegypti Mortality, PO, DA, GST, EST, Protease, Lysozyme-Like Activities, Fungal and Bacterial CFUs
Hydrophobic Nanoprecipitates of Cyclodextrin/Avermectins Inclusion Compounds Reveal Insecticide Activity Against Aedes Aegypti Larvae and Low Toxicity Against Fibroblasts
